Safety and nosocomial infection control in lung transplantation for a case of COVID-19 with end-stage ARDS
10.3760/cma.j.cn421203-20200402-00103
- VernacularTitle:一例晚期新型冠状病毒肺炎肺移植手术感染防控实践
- Author:
Guilong WANG
1
;
Dongxiao HUANG
;
Difei ZHOU
;
Wei WANG
;
Zhong QIN
;
Huizhi YU
;
Xiaoshan LI
;
Yanjuan WANG
;
Chunxiao HU
;
Jingyu CHEN
Author Information
1. 南京医科大学附属无锡人民医院麻醉科 214023
- From:
Chinese Journal of Organ Transplantation
2020;41(4):203-206
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the safety and nosocomial infection control measures of COVID-19 patients of end-stage respiratory failure after lung transplantation.Methods:Lung transplantation was performed for a COVID-19 patient with end-stage respiratory failure after a negative conversion of 2019-nCoV nucleic acid. Before operation, all medical staff received simulated training on nosocomial infection. The procedures were performed in an operation room with a negative pressure environment. The three-grade preventive strategy was implemented and wearing positive pressure protective mask of electric air supply required. During operation, the patient was managed according to the in-hospital protection process. The environment and medical instruments were disinfected after operation.Results:The operation was completed successfully. The 2019-nCoV nucleic acid test was negative for many times after operation. Participants were placed in medical isolation for 14 days after surgery. During the period, nucleic acid test was negative twice.Conclusions:As an exploratory treatment, lung transplantation is a safe option for end-stage respiratory failure in COVID-19 in operation room with a negative pressure environment and implementations of three-grade preventive strategy.
